Stage FocusSeed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
Synthetic BiologyBiotechMedTechAI Infrastructure
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Northpond Ventures is a life sciences and technology-focused VC with 74 portfolio companies, 5 IPOs, and 12 acquisitions including 908 Devices, Syapse, and Sherlock Biosciences. The fund has maintained consistent deployment with 6 investments in 2024 and 4 in early 2025, showing sustained activity in a market where many life sciences investors pulled back.
The synthetic biology angle is particula...
Notable Investments
9
908 DevicesS
SyapseS
SherlockSimilar Funds
Alwyn Capital
Brooklyn, United States
DeepTech NativeSynthetic BiologyBiotechMedTechSeedSeries A
a16z Bio + Crypto (Andreessen Horowitz)
Menlo Park, United States
GeneralistSynthetic BiologyCrypto / Web3BiotechSeedSeries A
Flagship Pioneering
Cambridge, United States
Pure DeepTechSynthetic BiologyBiotechAgriTechPre-SeedSeed
Illumina Ventures
San Diego, United States
Pure DeepTechSynthetic BiologyBiotechMedTechSeedSeries A
Newpath Partners
Boston, United States
Pure DeepTechSynthetic BiologyBiotechMedTechSeedSeries A
OMX Ventures
New York, United States
DeepTech NativeSynthetic BiologyBiotechAI InfrastructureSeedSeries A